Clinical characteristics influencing age at onset in psychotic disorders

Comprehensive Psychiatry

Volumn 50, Issue 1, 2009, Pages 13-19

  Öngür, Dost ^a   Lin, Lewei ^a   Cohen, Bruce M ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; CANNABIS ADDICTION; CLINICAL FEATURE; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; ONSET AGE; PANIC; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGED; BIPOLAR DISORDER; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; PANIC DISORDER; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 57049087476     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.comppsych.2008.06.002     Document Type: Article

References (43)

1. Kraepelin E. Psychiatry. A textbook for students and physicians Vol 2 (1899), Science History Publications, Canton
2. Goodwin F.K., and Jamison K.R. Manic-depressive illness. 2nd ed. (2007), Oxford University Press, New York
3. APA. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. 4th ed. (1994), American Psychiatric Press, Washington (DC)
4. Kendler K.S., and MacLean C.J. Estimating familial effects on age at onset and liability to schizophrenia. I. Results of a large sample family study. Genet Epidemiol 7 (1990) 409-417
5. Sham P.C., Jones P., Russell A., Gilvarry K., Bebbington P., Lewis S., et al. Age at onset, sex, and familial psychiatric morbidity in schizophrenia. Camberwell Collaborative Psychosis Study. Br J Psychiatry 165 (1994) 466-473
6. O'Mahony E., Corvin A., O'Connell R., Comerford C., Larsen B., Jones R., et al. Sibling pairs with affective disorders: resemblance of demographic and clinical features. Psychol Med 32 (2002) 55-61
7. Visscher P.M., Yazdi M.H., Jackson A.D., Schalling M., Lindblad K., Yuan Q.P., et al. Genetic survival analysis of age-at-onset of bipolar disorder: evidence for anticipation or cohort effect in families. Psychiatr Genet 11 (2001) 129-137
8. Benedetti F., Bernasconi A., Lorenzi C., Pontiggia A., Serretti A., Colombo C., et al. A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci Lett 355 (2004) 37-40
9. Etain B., Mathieu F., Rietschel M., Maier W., Albus M., McKeon P., et al. Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: supportive evidence for linkage at 3p14. Mol Psychiatry 11 (2006) 685-694
10. Faraone S.V., Lasky-Su J., Glatt S.J., Van Eerdewegh P., and Tsuang M.T. Early onset bipolar disorder: possible linkage to chromosome 9q34. Bipolar Disord 8 (2006) 144-151
11. Lin P.I., McInnis M.G., Potash J.B., Willour V.L., Mackinnon D.F., Miao K., et al. Assessment of the effect of age at onset on linkage to bipolar disorder: evidence on chromosomes 18p and 21q. Am J Hum Genet 77 (2005) 545-555
12. Wickham H., Walsh C., Asherson P., Gill M., Owen M.J., McGuffin P., et al. Familiality of clinical characteristics in schizophrenia. J Psychiatr Res 36 (2002) 325-329
13. Cardno A.G., Holmans P.A., Rees M.I., Jones L.A., McCarthy G.M., Hamshere M.L., et al. A genomewide linkage study of age at onset in schizophrenia. Am J Med Genet 105 (2001) 439-445
14. Bellivier F., Leroux M., Henry C., Rayah F., Rouillon F., Laplanche J.L., et al. Serotonin transporter gene polymorphism influences age at onset in patients with bipolar affective disorder. Neurosci Lett 334 (2002) 17-20
15. Numata S., Ueno S., Iga J., Yamauchi K., Hongwei S., Ohta K., et al. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neurosci Lett 401 (2006) 1-5
16. Maj M., Pirozzi R., Formicola A.M., Bartoli L., and Bucci P. Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary data. J Affect Disord 57 (2000) 95-98
17. Craddock N., O'Donovan M.C., and Owen M.J. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull 32 (2006) 9-16
18. Long J.S., and Ervin L.H. Using heteroscedasticity consistent standard errors in the linear regression model. Am Stat 54 (2000) 217-224
19. MacKinnon J.G., and White H. Some heteroskedasticity consistent covariance matrix estimators with improved finite sample properties. J Econom 29 (1985) 53-57
20. Regier D.A., Farmer M.E., et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the epidemiologic catchment area (ECA) study. JAMA 264 (1990) 2511-2518
21. Tien A.Y., and Eaton W.W. Psychopathologic precursors and sociodemographic risk factors for the schizophrenia syndrome. Arch Gen Psychiatry 49 (1992) 37-46
22. Brady K., Casto S., Lydiard R.B., Malcolm R., and Arana G. Substance abuse in an inpatient psychiatric sample. Am J Drug Alcohol Abuse 17 (1991) 389-397
23. Cassidy F., Ahearn E.P., and Carroll B.J. Substance abuse in bipolar disorder. Bipolar Disord 3 (2001) 181-188
24. Dixon L., Haas G., Weiden P.J., Sweeney J., and Frances A.J. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 148 (1991) 224-230
25. Henry C., Van den Bulke D., Bellivier F., Etain B., Rouillon F., and Leboyer M. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. J Clin Psychiatry 64 (2003) 331-335
26. Hambrecht M., and Hafner H. Substance abuse and the onset of schizophrenia. Biol Psychiatry 40 (1996) 1155-1163
27. Veen N.D., Selten J.P., van der Tweel I., Feller W.G., Hoek H.W., and Kahn R.S. Cannabis use and age at onset of schizophrenia. Am J Psychiatry 161 (2004) 501-506
28. Andreasson S., Allebeck P., Engstrom A., and Rydberg U. Cannibis and schizophrenia: a longitudinal study of Swedish conscripts. The Lancet 2 (1987) 1483-1485
29. Arseneault L., Cannon M., Witton J., and Murray R.M. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 184 (2004) 110-117
30. Fergusson D.M., Horwood L.J., and Swain-Campbell N.R. Cannabis dependence and psychotic symptoms in young people. Psychol Med 33 (2003) 15-21
31. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370 (2007) 319-328
32. Henquet C., Krabbendam L., de Graaf R., ten Have M., and van Os J. Cannabis use and expression of mania in the general population. J Affect Disord 95 (2006) 103-110
33. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 57 (2005) 1117-1127
34. Braga R.J., Mendlowicz M.V., Marrocos R.P., and Figueira I.L. Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life. J Psychiatr Res 39 (2005) 409-414
35. Braga R.J., Petrides G., and Figueira I. Anxiety disorders in schizophrenia. Compr Psychiatry 45 (2004) 460-468
36. Cassano G.B., Pini S., Saettoni M., and Dell'Osso L. Multiple anxiety disorder comorbidity in patients with mood spectrum disorders with psychotic features. Am J Psychiatry 156 (1999) 474-476
37. Simon N.M., Otto M.W., Wisniewski S.R., Fossey M., Sagduyu K., Frank E., et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 161 (2004) 2222-2229
38. Carpenter Jr. W.T., Strauss J.S., and Muleh S. Are there pathognomonic symptoms in schizophrenia? An empiric investigation of Schneider's first-rank symptoms. Arch Gen Psychiatry 28 (1973) 847-852
39. Perlis R.H., Miyahara S., Marangell L.B., Wisniewski S.R., Ostacher M., DelBello M.P., et al. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry 55 (2004) 875-881
40. Leonard S., Adler L.E., Benhammou K., Berger R., Breese C.R., Drebing C., et al. Smoking and mental illness. Pharmacol Biochem Behav 70 (2001) 561-570
41. Tohen M., Tsuang M.T., and Goodwin D.C. Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features. Am J Psychiatry. 149 (1992) 1580-1584
42. Abrams R., Taylor M.A., Hayman M.A., and Krishna N.R. Unipolar mania revisited. J Affect Disord 1 (1979) 59-68
43. Perugi G., Passino M.C., Toni C., Maremmani I., and Angst J. Is unipolar mania a distinct subtype?. Compr Psychiatry 48 (2007) 213-217